Selected research
Industry Growth & Trends
Global Oral Hair Loss Medication Industry Growth and Trends Forecast to 2032
Market perspective
The global Oral Hair Loss Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oral Hair Loss Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oral Hair Loss Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oral Hair Loss Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oral Hair Loss Medication include Zhejiang Xianju Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Merck & Co., Pfizer, China Resources Double-crane Pharmaceutical, Teva Pharmaceuticals, Sandoz, Organon Pharma and Marksans Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oral Hair Loss Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oral Hair Loss Medication market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Hair Loss Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Hair Loss Medication.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Oral Hair Loss Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oral Hair Loss Medication Market by Company
Zhejiang Xianju Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Merck & Co.
Pfizer
China Resources Double-crane Pharmaceutical
Teva Pharmaceuticals
Sandoz
Organon Pharma
Marksans Pharma
Aurobindo Pharma
Oral Hair Loss Medication Segment by Type
Finasteride
Minoxidil
Oral Hair Loss Medication Segment by Application
Male Hair Loss
Female Hair Loss
Oral Hair Loss Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Hair Loss Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Hair Loss Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Hair Loss Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Hair Loss Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Hair Loss Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Major Company of Finasteride
Table 2. Major Company of Minoxidil
Table 3. Global Oral Hair Loss Medication Sales by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Global Oral Hair Loss Medication Sales by Type (2021-2026) & (K Units)
Table 5. Global Oral Hair Loss Medication Sales Market Share in Volume by Type (2021-2026)
Table 6. Global Oral Hair Loss Medication Sales by Type (2021-2026) & (US$ Million)
Table 7. Global Oral Hair Loss Medication Sales Market Share in Value by Type (2021-2026)
Table 8. Global Oral Hair Loss Medication Price by Type (2021-2026) & (US$/Unit)
Table 9. Global Oral Hair Loss Medication Sales by Type (2027-2032) & (K Units)
Table 10. Global Oral Hair Loss Medication Sales Market Share in Volume by Type (2027-2032)
Table 11. Global Oral Hair Loss Medication Sales by Type (2027-2032) & (US$ Million)
Table 12. Global Oral Hair Loss Medication Sales Market Share in Value by Type (2027-2032)
Table 13. Global Oral Hair Loss Medication Price by Type (2027-2032) & (US$/Unit)
Table 14. North America Oral Hair Loss Medication Sales by Type (2021-2026) & (K Units)
Table 15. North America Oral Hair Loss Medication Sales by Type (2021-2026) & (US$ Million)
Table 16. Europe Oral Hair Loss Medication Sales by Type (2021-2026) & (K Units)
Table 17. Europe Oral Hair Loss Medication Sales by Type (2021-2026) & (US$ Million)
Table 18. Asia-Pacific Oral Hair Loss Medication Sales by Type (2021-2026) & (K Units)
Table 19. Asia-Pacific Oral Hair Loss Medication Sales by Type (2021-2026) & (US$ Million)
Table 20. Latin America Oral Hair Loss Medication Sales by Type (2021-2026) & (K Units)
Table 21. Latin America Oral Hair Loss Medication Sales by Type (2021-2026) & (US$ Million)
Table 22. Middle East and Africa Oral Hair Loss Medication Sales by Type (2021-2026) & (K Units)
Table 23. Middle East and Africa Oral Hair Loss Medication Sales by Type (2021-2026) & (US$ Million)
Table 24. Oral Hair Loss Medication Industry Trends
Table 25. Oral Hair Loss Medication Industry Drivers
Table 26. Oral Hair Loss Medication Industry Opportunities and Challenges
Table 27. Oral Hair Loss Medication Industry Restraints
Table 28. Global Oral Hair Loss Medication Sales Revenue by Company (US$ Million) & (2021-2026)
Table 29. Global Oral Hair Loss Medication Revenue Market Share by Company (2021-2026)
Table 30. Global Oral Hair Loss Medication Sales by Company (2021-2026) & (K Units)
Table 31. Global Oral Hair Loss Medication Sales Share by Company (2021-2026)
Table 32. Global Oral Hair Loss Medication Market Price by Company (2021-2026) & (US$/Unit)
Table 33. Global Oral Hair Loss Medication Industry Company Ranking, 2024 VS 2025 VS 2026
Table 34. Global Oral Hair Loss Medication Major Company Production Sites and Headquarters
Table 35. Global Oral Hair Loss Medication Company, Product Type & Application
Table 36. Global Oral Hair Loss Medication Company Establishment Date
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Oral Hair Loss Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 39. Global Oral Hair Loss Medication Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032
Table 40. Global Oral Hair Loss Medication Sales by Region (2021-2026) & (K Units)
Table 41. Global Oral Hair Loss Medication Sales Market Share in Volume by Region (2021-2026)
Table 42. Global Oral Hair Loss Medication Sales by Region (2021-2026) & (US$ Million)
Table 43. Global Oral Hair Loss Medication Sales Market Share in Value by Region (2021-2026)
Table 44. Global Oral Hair Loss Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 45. Global Oral Hair Loss Medication Sales by Region (2027-2032) & (K Units)
Table 46. Global Oral Hair Loss Medication Sales Market Share in Volume by Region (2027-2032)
Table 47. Global Oral Hair Loss Medication Sales by Region (2027-2032) & (US$ Million)
Table 48. Global Oral Hair Loss Medication Sales Market Share in Value by Region (2027-2032)
Table 49. Global Oral Hair Loss Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032)
Table 50. Global Oral Hair Loss Medication Sales by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 51. Global Oral Hair Loss Medication Sales by Application (2021-2026) & (K Units)
Table 52. Global Oral Hair Loss Medication Sales Market Share in Volume by Application (2021-2026)
Table 53. Global Oral Hair Loss Medication Sales by Application (2021-2026) & (US$ Million)
Table 54. Global Oral Hair Loss Medication Sales Market Share in Value by Application (2021-2026)
Table 55. Global Oral Hair Loss Medication Price by Application (2021-2026) & (US$/Unit)
Table 56. Global Oral Hair Loss Medication Sales by Application (2027-2032) & (K Units)
Table 57. Global Oral Hair Loss Medication Sales Market Share in Volume by Application (2027-2032)
Table 58. Global Oral Hair Loss Medication Sales by Application (2027-2032) & (US$ Million)
Table 59. Global Oral Hair Loss Medication Sales Market Share in Value by Application (2027-2032)
Table 60. Global Oral Hair Loss Medication Price by Application (2027-2032) & (US$/Unit)
Table 61. North America Oral Hair Loss Medication Sales by Application (2021-2026) & (K Units)
Table 62. North America Oral Hair Loss Medication Sales by Application (2021-2026) & (US$ Million)
Table 63. Europe Oral Hair Loss Medication Sales by Application (2021-2026) & (K Units)
Table 64. Europe Oral Hair Loss Medication Sales by Application (2021-2026) & (US$ Million)
Table 65. Asia-Pacific Oral Hair Loss Medication Sales by Application (2021-2026) & (K Units)
Table 66. Asia-Pacific Oral Hair Loss Medication Sales by Application (2021-2026) & (US$ Million)
Table 67. Latin America Oral Hair Loss Medication Sales by Application (2021-2026) & (K Units)
Table 68. Latin America Oral Hair Loss Medication Sales by Application (2021-2026) & (US$ Million)
Table 69. Middle East and Africa Oral Hair Loss Medication Sales by Application (2021-2026) & (K Units)
Table 70. Middle East and Africa Oral Hair Loss Medication Sales by Application (2021-2026) & (US$ Million)
Table 71. Zhejiang Xianju Pharmaceutical Company Information
Table 72. Zhejiang Xianju Pharmaceutical Business Overview
Table 73. Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 74. Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Product Portfolio
Table 75. Zhejiang Xianju Pharmaceutical Recent Development
Table 76. Shanxi Ante Bio-pharmaceutical Company Information
Table 77. Shanxi Ante Bio-pharmaceutical Business Overview
Table 78. Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Product Portfolio
Table 80. Shanxi Ante Bio-pharmaceutical Recent Development
Table 81. Merck & Co. Company Information
Table 82. Merck & Co. Business Overview
Table 83. Merck & Co. Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Merck & Co. Oral Hair Loss Medication Product Portfolio
Table 85. Merck & Co. Recent Development
Table 86. Pfizer Company Information
Table 87. Pfizer Business Overview
Table 88. Pfizer Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Pfizer Oral Hair Loss Medication Product Portfolio
Table 90. Pfizer Recent Development
Table 91. China Resources Double-crane Pharmaceutical Company Information
Table 92. China Resources Double-crane Pharmaceutical Business Overview
Table 93. China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Product Portfolio
Table 95. China Resources Double-crane Pharmaceutical Recent Development
Table 96. Teva Pharmaceuticals Company Information
Table 97. Teva Pharmaceuticals Business Overview
Table 98. Teva Pharmaceuticals Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Teva Pharmaceuticals Oral Hair Loss Medication Product Portfolio
Table 100. Teva Pharmaceuticals Recent Development
Table 101. Sandoz Company Information
Table 102. Sandoz Business Overview
Table 103. Sandoz Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Sandoz Oral Hair Loss Medication Product Portfolio
Table 105. Sandoz Recent Development
Table 106. Organon Pharma Company Information
Table 107. Organon Pharma Business Overview
Table 108. Organon Pharma Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Organon Pharma Oral Hair Loss Medication Product Portfolio
Table 110. Organon Pharma Recent Development
Table 111. Marksans Pharma Company Information
Table 112. Marksans Pharma Business Overview
Table 113. Marksans Pharma Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Marksans Pharma Oral Hair Loss Medication Product Portfolio
Table 115. Marksans Pharma Recent Development
Table 116. Aurobindo Pharma Company Information
Table 117. Aurobindo Pharma Business Overview
Table 118. Aurobindo Pharma Oral Hair Loss Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Aurobindo Pharma Oral Hair Loss Medication Product Portfolio
Table 120. Aurobindo Pharma Recent Development
Table 121. North America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 122. North America Oral Hair Loss Medication Sales by Country (2021-2026) & (K Units)
Table 123. North America Oral Hair Loss Medication Sales Market Share by Country (2021-2026)
Table 124. North America Oral Hair Loss Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 125. North America Oral Hair Loss Medication Sales Market Share Forecast by Country (2027-2032)
Table 126. North America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 127. North America Oral Hair Loss Medication Market Size by Country (2021-2026) & (US$ Million)
Table 128. North America Oral Hair Loss Medication Market Share by Country (2021-2026)
Table 129. North America Oral Hair Loss Medication Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 130. North America Oral Hair Loss Medication Market Share Forecast by Country (2027-2032)
Table 131. Europe Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 132. Europe Oral Hair Loss Medication Sales by Country (2021-2026) & (K Units)
Table 133. Europe Oral Hair Loss Medication Sales Market Share by Country (2021-2026)
Table 134. Europe Oral Hair Loss Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 135. Europe Oral Hair Loss Medication Sales Market Share Forecast by Country (2027-2032)
Table 136. Europe Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 137. Europe Oral Hair Loss Medication Market Size by Country (2021-2026) & (US$ Million)
Table 138. Europe Oral Hair Loss Medication Market Share by Country (2021-2026)
Table 139. Europe Oral Hair Loss Medication Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 140. Europe Oral Hair Loss Medication Market Share Forecast by Country (2027-2032)
Table 141. Asia-Pacific Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 142. Asia-Pacific Oral Hair Loss Medication Sales by Country (2021-2026) & (K Units)
Table 143. Asia-Pacific Oral Hair Loss Medication Sales Market Share by Country (2021-2026)
Table 144. Asia-Pacific Oral Hair Loss Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 145. Asia-Pacific Oral Hair Loss Medication Sales Market Share Forecast by Country (2027-2032)
Table 146. Asia-Pacific Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 147. Asia-Pacific Oral Hair Loss Medication Market Size by Country (2021-2026) & (US$ Million)
Table 148. Asia-Pacific Oral Hair Loss Medication Market Share by Country (2021-2026)
Table 149. Asia-Pacific Oral Hair Loss Medication Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 150. Asia-Pacific Oral Hair Loss Medication Market Share Forecast by Country (2027-2032)
Table 151. Latin America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 152. Latin America Oral Hair Loss Medication Sales by Country (2021-2026) & (K Units)
Table 153. Latin America Oral Hair Loss Medication Sales Market Share by Country (2021-2026)
Table 154. Latin America Oral Hair Loss Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 155. Latin America Oral Hair Loss Medication Sales Market Share Forecast by Country (2027-2032)
Table 156. Latin America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 157. Latin America Oral Hair Loss Medication Market Size by Country (2021-2026) & (US$ Million)
Table 158. Latin America Oral Hair Loss Medication Market Share by Country (2021-2026)
Table 159. Latin America Oral Hair Loss Medication Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 160. Latin America Oral Hair Loss Medication Market Share Forecast by Country (2027-2032)
Table 161. Middle East and Africa Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 162. Middle East and Africa Oral Hair Loss Medication Sales by Country (2021-2026) & (K Units)
Table 163. Middle East and Africa Oral Hair Loss Medication Sales Market Share by Country (2021-2026)
Table 164. Middle East and Africa Oral Hair Loss Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 165. Middle East and Africa Oral Hair Loss Medication Sales Market Share Forecast by Country (2027-2032)
Table 166. Middle East and Africa Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 167. Middle East and Africa Oral Hair Loss Medication Market Size by Country (2021-2026) & (US$ Million)
Table 168. Middle East and Africa Oral Hair Loss Medication Market Share by Country (2021-2026)
Table 169. Middle East and Africa Oral Hair Loss Medication Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 170. Middle East and Africa Oral Hair Loss Medication Market Share Forecast by Country (2027-2032)
Table 171. Key Raw Materials
Table 172. Raw Materials Key Suppliers
Table 173. Oral Hair Loss Medication Distributors List
Table 174. Oral Hair Loss Medication Customers List
Table 175. Research Programs/Design for This Report
Table 176. Authors List of This Report
Table 177. Secondary Sources
Table 178. Primary Sources
List of Figures
Figure 1. Oral Hair Loss Medication Image
Figure 2. Global Oral Hair Loss Medication Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Oral Hair Loss Medication Market Size (2021-2032) & (US$ Million)
Figure 4. Global Oral Hair Loss Medication Sales (2021-2032) & (K Units)
Figure 5. Finasteride Image
Figure 6. Global Finasteride Sales YoY Growth (2021-2032) & (K Units)
Figure 7. Minoxidil Image
Figure 8. Global Minoxidil Sales YoY Growth (2021-2032) & (K Units)
Figure 9. Global Oral Hair Loss Medication Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 10. Global Oral Hair Loss Medication Market Share by Type 2025 VS 2032
Figure 11. North America Oral Hair Loss Medication Sales Market Share in Volume by Type in 2025
Figure 12. North America Oral Hair Loss Medication Sales Market Share in Value by Type in 2025
Figure 13. Europe Oral Hair Loss Medication Sales Market Share in Volume by Type in 2025
Figure 14. Europe Oral Hair Loss Medication Sales Market Share in Value by Type in 2025
Figure 15. Asia-Pacific Oral Hair Loss Medication Sales Market Share in Volume by Type in 2025
Figure 16. Asia-Pacific Oral Hair Loss Medication Sales Market Share in Value by Type in 2025
Figure 17. Latin America Oral Hair Loss Medication Sales Market Share in Volume by Type in 2025
Figure 18. Latin America Oral Hair Loss Medication Sales Market Share in Value by Type in 2025
Figure 19. Middle East and Africa Oral Hair Loss Medication Sales Market Share in Volume by Type in 2025
Figure 20. Middle East and Africa Oral Hair Loss Medication Sales Market Share in Value by Type in 2025
Figure 21. Global Top 5 and 10 Oral Hair Loss Medication Players Market Share by Revenue in 2025
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Male Hair Loss Image
Figure 24. Global Male Hair Loss Sales YoY Growth (2021-2032) & (K Units)
Figure 25. Female Hair Loss Image
Figure 26. Global Female Hair Loss Sales YoY Growth (2021-2032) & (K Units)
Figure 27. Global Oral Hair Loss Medication Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 28. Global Oral Hair Loss Medication Market Share by Application 2025 VS 2032
Figure 29. North America Oral Hair Loss Medication Sales Market Share in Volume by Application in 2025
Figure 30. North America Oral Hair Loss Medication Sales Market Share in Value by Application in 2025
Figure 31. Europe Oral Hair Loss Medication Sales Market Share in Volume by Application in 2025
Figure 32. Europe Oral Hair Loss Medication Sales Market Share in Value by Application in 2025
Figure 33. Asia-Pacific Oral Hair Loss Medication Sales Market Share in Volume by Application in 2025
Figure 34. Asia-Pacific Oral Hair Loss Medication Sales Market Share in Value by Application in 2025
Figure 35. Latin America Oral Hair Loss Medication Sales Market Share in Volume by Application in 2025
Figure 36. Latin America Oral Hair Loss Medication Sales Market Share in Value by Application in 2025
Figure 37. Middle East and Africa Oral Hair Loss Medication Sales Market Share in Volume by Application in 2025
Figure 38. Middle East and Africa Oral Hair Loss Medication Sales Market Share in Value by Application in 2025
Figure 39. North America Oral Hair Loss Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 40. North America Oral Hair Loss Medication Sales Share by Country: 2021 VS 2025 VS 2032
Figure 41. North America Oral Hair Loss Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 42. North America Oral Hair Loss Medication Market Share by Country: 2021 VS 2025 VS 2032
Figure 43. Europe Oral Hair Loss Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 44. Europe Oral Hair Loss Medication Sales Share by Country: 2021 VS 2025 VS 2032
Figure 45. Europe Oral Hair Loss Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 46. Europe Oral Hair Loss Medication Market Share by Country: 2021 VS 2025 VS 2032
Figure 47. Asia-Pacific Oral Hair Loss Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 48. Asia-Pacific Oral Hair Loss Medication Sales Share by Country: 2021 VS 2025 VS 2032
Figure 49. Asia-Pacific Oral Hair Loss Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 50. Asia-Pacific Oral Hair Loss Medication Market Share by Country: 2021 VS 2025 VS 2032
Figure 51. Latin America Oral Hair Loss Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 52. Latin America Oral Hair Loss Medication Sales Share by Country: 2021 VS 2025 VS 2032
Figure 53. Latin America Oral Hair Loss Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 54. Latin America Oral Hair Loss Medication Market Share by Country: 2021 VS 2025 VS 2032
Figure 55. Middle East and Africa Oral Hair Loss Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 56. Middle East and Africa Oral Hair Loss Medication Sales Share by Country: 2021 VS 2025 VS 2032
Figure 57. Middle East and Africa Oral Hair Loss Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Middle East and Africa Oral Hair Loss Medication Market Share by Country: 2021 VS 2025 VS 2032
Figure 59. Oral Hair Loss Medication Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Oral Hair Loss Medication Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Scope & coverage.
Types
- Finasteride
- Minoxidil
Applications
- Male Hair Loss
- Female Hair Loss
Companies covered
- Zhejiang Xianju Pharmaceutical
- Shanxi Ante Bio-pharmaceutical
- Merck & Co.
- Pfizer
- China Resources Double-crane Pharmaceutical
- Teva Pharmaceuticals
- Sandoz
- Organon Pharma
- Marksans Pharma
- Aurobindo Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oral Hair Loss Medication Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Oral Hair Loss Medication Sales Estimates and Forecasts (2021-2032)
- 1.3 Oral Hair Loss Medication Market by Type
- 1.3.1 Finasteride
- 1.3.2 Minoxidil
- 1.4 Global Oral Hair Loss Medication Market Size by Type
- 1.4.1 Global Oral Hair Loss Medication Market Size Overview by Type (2021-2032)
- 1.4.2 Global Oral Hair Loss Medication Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Oral Hair Loss Medication Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Oral Hair Loss Medication Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Oral Hair Loss Medication Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Oral Hair Loss Medication Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Oral Hair Loss Medication Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Oral Hair Loss Medication Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Oral Hair Loss Medication Industry Trends
- 2.2 Oral Hair Loss Medication Industry Drivers
- 2.3 Oral Hair Loss Medication Industry Opportunities and Challenges
- 2.4 Oral Hair Loss Medication Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Oral Hair Loss Medication Revenue (2021-2026)
- 3.2 Global Top Players by Oral Hair Loss Medication Sales (2021-2026)
- 3.3 Global Top Players by Oral Hair Loss Medication Price (2021-2026)
- 3.4 Global Oral Hair Loss Medication Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oral Hair Loss Medication Major Company Production Sites & Headquarters
- 3.6 Global Oral Hair Loss Medication Company, Product Type & Application
- 3.7 Global Oral Hair Loss Medication Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oral Hair Loss Medication Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oral Hair Loss Medication Players Market Share by Revenue in 2025
- 3.8.3 2025 Oral Hair Loss Medication Tier 1, Tier 2, and Tier 3
4 Oral Hair Loss Medication Regional Status and Outlook
- 4.1 Global Oral Hair Loss Medication Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Oral Hair Loss Medication Historic Market Size by Region
- 4.2.1 Global Oral Hair Loss Medication Sales in Volume by Region (2021-2026)
- 4.2.2 Global Oral Hair Loss Medication Sales in Value by Region (2021-2026)
- 4.2.3 Global Oral Hair Loss Medication Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Oral Hair Loss Medication Forecasted Market Size by Region
- 4.3.1 Global Oral Hair Loss Medication Sales in Volume by Region (2027-2032)
- 4.3.2 Global Oral Hair Loss Medication Sales in Value by Region (2027-2032)
- 4.3.3 Global Oral Hair Loss Medication Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Hair Loss Medication by Application
- 5.1 Oral Hair Loss Medication Market by Application
- 5.1.1 Male Hair Loss
- 5.1.2 Female Hair Loss
- 5.2 Global Oral Hair Loss Medication Market Size by Application
- 5.2.1 Global Oral Hair Loss Medication Market Size Overview by Application (2021-2032)
- 5.2.2 Global Oral Hair Loss Medication Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Oral Hair Loss Medication Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Oral Hair Loss Medication Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Oral Hair Loss Medication Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Oral Hair Loss Medication Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Oral Hair Loss Medication Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Oral Hair Loss Medication Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zhejiang Xianju Pharmaceutical
- 6.1.1 Zhejiang Xianju Pharmaceutical Company Information
- 6.1.2 Zhejiang Xianju Pharmaceutical Business Overview
- 6.1.3 Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Product Portfolio
- 6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 6.2 Shanxi Ante Bio-pharmaceutical
- 6.2.1 Shanxi Ante Bio-pharmaceutical Company Information
- 6.2.2 Shanxi Ante Bio-pharmaceutical Business Overview
- 6.2.3 Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Product Portfolio
- 6.2.5 Shanxi Ante Bio-pharmaceutical Recent Developments
- 6.3 Merck & Co.
- 6.3.1 Merck & Co. Company Information
- 6.3.2 Merck & Co. Business Overview
- 6.3.3 Merck & Co. Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck & Co. Oral Hair Loss Medication Product Portfolio
- 6.3.5 Merck & Co. Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Oral Hair Loss Medication Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 China Resources Double-crane Pharmaceutical
- 6.5.1 China Resources Double-crane Pharmaceutical Company Information
- 6.5.2 China Resources Double-crane Pharmaceutical Business Overview
- 6.5.3 China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Product Portfolio
- 6.5.5 China Resources Double-crane Pharmaceutical Recent Developments
- 6.6 Teva Pharmaceuticals
- 6.6.1 Teva Pharmaceuticals Company Information
- 6.6.2 Teva Pharmaceuticals Business Overview
- 6.6.3 Teva Pharmaceuticals Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Teva Pharmaceuticals Oral Hair Loss Medication Product Portfolio
- 6.6.5 Teva Pharmaceuticals Recent Developments
- 6.7 Sandoz
- 6.7.1 Sandoz Company Information
- 6.7.2 Sandoz Business Overview
- 6.7.3 Sandoz Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sandoz Oral Hair Loss Medication Product Portfolio
- 6.7.5 Sandoz Recent Developments
- 6.8 Organon Pharma
- 6.8.1 Organon Pharma Company Information
- 6.8.2 Organon Pharma Business Overview
- 6.8.3 Organon Pharma Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Organon Pharma Oral Hair Loss Medication Product Portfolio
- 6.8.5 Organon Pharma Recent Developments
- 6.9 Marksans Pharma
- 6.9.1 Marksans Pharma Company Information
- 6.9.2 Marksans Pharma Business Overview
- 6.9.3 Marksans Pharma Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Marksans Pharma Oral Hair Loss Medication Product Portfolio
- 6.9.5 Marksans Pharma Recent Developments
- 6.10 Aurobindo Pharma
- 6.10.1 Aurobindo Pharma Company Information
- 6.10.2 Aurobindo Pharma Business Overview
- 6.10.3 Aurobindo Pharma Oral Hair Loss Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Aurobindo Pharma Oral Hair Loss Medication Product Portfolio
- 6.10.5 Aurobindo Pharma Recent Developments
7 North America by Country
- 7.1 North America Oral Hair Loss Medication Sales by Country
- 7.1.1 North America Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Oral Hair Loss Medication Sales by Country (2021-2026)
- 7.1.3 North America Oral Hair Loss Medication Sales Forecast by Country (2027-2032)
- 7.2 North America Oral Hair Loss Medication Market Size by Country
- 7.2.1 North America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Oral Hair Loss Medication Market Size by Country (2021-2026)
- 7.2.3 North America Oral Hair Loss Medication Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Oral Hair Loss Medication Sales by Country
- 8.1.1 Europe Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Oral Hair Loss Medication Sales by Country (2021-2026)
- 8.1.3 Europe Oral Hair Loss Medication Sales Forecast by Country (2027-2032)
- 8.2 Europe Oral Hair Loss Medication Market Size by Country
- 8.2.1 Europe Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Oral Hair Loss Medication Market Size by Country (2021-2026)
- 8.2.3 Europe Oral Hair Loss Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Oral Hair Loss Medication Sales by Country
- 9.1.1 Asia-Pacific Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Oral Hair Loss Medication Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Oral Hair Loss Medication Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Oral Hair Loss Medication Market Size by Country
- 9.2.1 Asia-Pacific Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Oral Hair Loss Medication Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Oral Hair Loss Medication Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Oral Hair Loss Medication Sales by Country
- 10.1.1 South America Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Oral Hair Loss Medication Sales by Country (2021-2026)
- 10.1.3 South America Oral Hair Loss Medication Sales Forecast by Country (2027-2032)
- 10.2 South America Oral Hair Loss Medication Market Size by Country
- 10.2.1 South America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Oral Hair Loss Medication Market Size by Country (2021-2026)
- 10.2.3 South America Oral Hair Loss Medication Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Oral Hair Loss Medication Sales by Country
- 11.1.1 Middle East and Africa Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Oral Hair Loss Medication Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Oral Hair Loss Medication Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Oral Hair Loss Medication Market Size by Country
- 11.2.1 Middle East and Africa Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Oral Hair Loss Medication Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Oral Hair Loss Medication Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Oral Hair Loss Medication Value Chain Analysis
- 12.1.1 Oral Hair Loss Medication Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Oral Hair Loss Medication Production Mode & Process
- 12.2 Oral Hair Loss Medication Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Oral Hair Loss Medication Distributors
- 12.2.3 Oral Hair Loss Medication Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst